Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Acta Medica Scandinavica

• Publication date

  2009-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.0954-6820.1986.TB02742.XPMID 3776689
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fatty acid composition of serum and adipose tissue lipids in males with chronic renal failure. Relations to serum lipoproteins and clinical factors.

  2009cited by this paper
• The uremic dyslipoproteinemia: its characteristics and relations to clinical factors.

  2009cited by this paper
• Intravenous fat tolerance test with Intralipid in chronic renal failure.

  2009cited by this paper
• Serum lipid and lipoprotein concentrations in chronic uremia.

  2009cited by this paper
• Glucose absorption and weight change in 18 months of continuous ambulatory peritoneal dialysis.

  1984cited by this paper
• Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure.

  1984cited by this paper
• Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis.

  1983cited by this paper
• Lipid Abnormalities in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

  1983cited by this paper
• Continuous ambulatory peritoneal dialysis in Australia, Europe, and the United States: 1981.

  1983cited by this paper
• Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal.

  1982cited by this paper
• Clinical and biological effects of low doses of (3 amino‐1 hydroxypropylidene)‐1,1‐bisphosphonate (APD) in Paget's disease of bone

  1982cited by this paper
• The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins.

  1982cited by this paper
• Accelerated Hypertriglyceridemia in Patients on Continuous Ambulatory Peritoneal Dialysis - A Preventable Abnormality

  1981cited by this paper
• Glucose absorption during continuous ambulatory peritoneal dialysis.

  1981cited by this paper
• Dialysis hyperlipemia: response to dietary manipulations.

  1980cited by this paper
• An inquiry into the mechanism of hypertriglyceridemia in patients with chronic renal failure.

  1980cited by this paper
• Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

  1979cited by this paper
• Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.

  1976cited by this paper
• Studies of the mechanisms of carbohydrate-induced lipaemia in normal man.

  1973cited by this paper
• Role of dietary protein upon serum cholesterol level in malnourished subjects.

  1970cited by this paper

• Markers of Oxidative Stress, Inflammation, and Endothelial Dysfunction in Diabetic and Nondiabetic Patients with Chronic Kidney Disease on Peritoneal Dialysis

  2022cites this paper
• A Model To Estimate Glucose Absorption in Peritoneal Dialysis: A Pilot Study.

  2020cites this paper
• Cardiovascular risk factor prevalence, mortality and cardiovascular disease incidence in patients who initiated renal replacement therapy in childhood : systematic review and analyses of two renal registries

  2017cites this paper
• The value of time-averaged serum high-sensitivity C-reactive protein in prediction of mortality and dropout in peritoneal dialysis patients

  2017cites this paper
• The Importance of Muscular Strength in Athletic Performance

  2016cites this paper
• serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis

  2015cites this paper
• The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level

  2013cites this paper
• Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

  2013cites this paper
• Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients—a Randomized Crossover Trial

  2012cites this paper
• Effects of fatigue on running mechanics associated with tibial stress fracture risk.

  2012cites this paper
• Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic hemodialysis and peritoneal dialysis patients.

  2011cites this paper
• Evaluation of Taurine as an Osmotic Agent for Peritoneal Dialysis Solution

  2009cites this paper
• Long-Term Modality-Related Mortality Analysis in Incident Dialysis Patients

  2009cites this paper
• Icodextrin: an alternative peritoneal dialysis fluid

  2008cites this paper
• Peritoneal dialysis with amino acid solutions: fluid and solute transport kinetics.

  2008cites this paper
• Initiation of Glucose-Based Peritoneal Dialysis Is Associated with Increased Prevalence of Metabolic Syndrome in Non-Diabetic Patients with End-Stage Renal Disease

  2008cites this paper
• CAPD with Icodextrin solution preserved the residual renal graft function and improved the quality of life in cadaveric renal transplanted ESRD patients with deteriorated graft function

  2007cites this paper
• Effect of Peritoneal Dialysis Solution Type on Serum Lipid Levels in End-Stage Renal Disease

  2007cites this paper
• Statins for Treatment of Dyslipidemia in Chronic Kidney Disease

  2006cites this paper
• Running training alters fiber type composition in spinal muscles

  2006cites this paper
• [Peritoneal dialysis in patients with diabetes mellitus].

  2005cites this paper
• Peritonealdialyse bei Diabetikern

  2005cites this paper
• Inflammation and metabolism in peritoneal dialysis - factors associated with peritoneal function, peritonitis and dialysis solutions

  2005cites this paper
• INFLAMMATION AND METABOLISM IN PERITONEAL DIALYSIS – FACTORS ASSOCIATED WITH PERITONEAL FUNCTION , PERITONITIS AND DIALYSIS SOLUTIONS

  2005influential citation
• Benefit of Glucose-Free Dialysis Solutions on Glucose and Lipid Metabolism in Peritoneal Dialysis Patients

  2005cites this paper
• Managing metabolic complications of peritoneal dialysis.

  2004cites this paper
• Lipids and atherosclerosis

  2004cites this paper
• Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis

  2004cites this paper
• A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.

  2004cites this paper
• Alterations in Lipoprotein Composition in Peritoneal Dialysis Patients

  2002cites this paper
• Nutritional Status in Peritoneal Dialysis: Studies in Body Composition, Lipoprotein Metabolism and Peritoneal Function

  2002cites this paper
• Metabolic and laboratory effects of icodextrin.

  2002cites this paper
• Beneficial Effect of Icodextrin on the Hypertriglyceridemia of CAPD Patients

  2002cites this paper
• Long-Term Perspective on Utility of Peritoneal Dialysis in Diabetes

  2002cites this paper
• Effects of Peritoneal Dialysis with an Overnight Icodextrin Dwell on Parameters of Glucose and LIPID Metabolism

  2001cites this paper
• Kinetic studies of dipeptide-based and amino acid-based peritoneal dialysis solutions.

  2001cites this paper
• Association of Hypertriglyceridemia and Insulin Resistance in UREMIC Patients Undergoing CAPD

  2001influential citation
• Peritoneal dialysis in diabetic patients.

  2001cites this paper
• Peritoneal dialysis solutions and systems

  2000cites this paper
• Dyslipidemia in Peritoneal Dialysis — Relation to Dialytic Variables

  2000cites this paper
• Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease.

  2000cites this paper
• Nutritional aspects of peritoneal dialysis

  2000cites this paper
• Mortality in peritoneal dialysis patients.

  1999cites this paper
• Recommendations for the Treatment of Lipid Disorders in Patients on Peritoneal Dialysis

  1999cites this paper
• Mononuclear leucocyte function tests in the assessment of the biocompatibility of peritoneal dialysis fluids.

  1999cites this paper
• Genesis of Atherosclerosis in Uremic Patients

  1999cites this paper
• Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.

  1999cites this paper
• Liver Cell Reactive Components in Peritoneal Dialysis Fluids

  1999cites this paper
• Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRD.

  1998cites this paper
• Diabetic Renal-Retinal Syndrome

  1998cites this paper
• Increase of Intra-Abdominal Fat in Patients Treated with Continuous Ambulatory Peritoneal Dialysis

  1998cites this paper
• Effect of enteral feeding on lipid subfractions in children with chronic renal failure

  1998cites this paper
• Comparison of Lipid Profiles in Long-Term CAPD and Hemodialysis Patients

  1998cites this paper
• Effect of enteral feeding on lipid subfractions in children with chronic renal failure

  1998influential citation
• Experimental use of raffinose as an osmotic agent for peritoneal dialysis.

  1998cites this paper
• Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors.

  1998cites this paper
• Lipid abnormalities in end stage renal disease.

  1998cites this paper
• Six-Month Prospective Cross-Over Study to Determine the Effects of 1.1% Amino Acid Dialysate on Lipid Metabolism in Patients on Continuous Ambulatory Peritoneal Dialysis

  1997cites this paper
• Is Capd Atherogenic?

  1997cites this paper
• Low‐density lipoprotein subfraction profiles in dialysis patients

  1997cites this paper
• In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.

  1997cites this paper
• Resistance of lipoproteins from continuous ambulatory peritoneal dialysis patients to in vitro oxidation.

  1997cites this paper
• Causes, Risks and Therapy of Hyperlipidemia in Chronic Dialysis Patients

  1997cites this paper
• Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.

  1997cites this paper
• Atherosclerosis and arteriosclerosis in chronic renal failure.

  1997cites this paper
• Cardiac disease in chronic uremia: pathogenesis.

  1997cites this paper
• The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.

  1997cites this paper
• Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years.

  1996cites this paper
• Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.

  1996cites this paper
• Solutions for Peritoneal Dialysis

  1996cites this paper
• Dyslipidemia in renal disease.

  1996cites this paper
• Lipoprotein metabolism in renal replacement therapy: a review.

  1996cites this paper
• Abnormalities of lipoprotein metabolism in CAPD patients.

  1996cites this paper
• Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis.

  1996cites this paper
• Diagnosis and classification of dyslipidemia in renal disease.

  1996cites this paper
• Energy intake in patients on continuous ambulatory peritoneal dialysis and haemodialysis

  1996cites this paper
• Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.

  1996cites this paper
• Nutritional management of the continuous ambulatory peritoneal dialysis patient.

  1996cites this paper
• Hyperlipoproteinemia in patients on hemodialysis and CAPD

  1995cites this paper
• Lipids and atherosclerosis.

  1995cites this paper
• Albumin-based solutions for peritoneal dialysis: investigations with a rat model.

  1995cites this paper
• Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients.

  1995cites this paper
• Lipid Parameters Including Lipoprotein (A) in Patients Undergoing CAPD and Hemodialysis

  1995cites this paper
• Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.

  1994cites this paper
• CAPD systems and solutions

  1994cites this paper
• Treatment options and strategies in uremia: current trends and future directions.

  1994cites this paper
• Nutritional requirements of peritoneal dialysis patients

  1994cites this paper
• Peritoneal Transport during Dialysis with Amino Acid-Based Solutions

  1993cites this paper
• Lipoprotein (a) levels in end-stage renal failure and renal transplantation.

  1993cites this paper
• Lipoprotein metabolism and renal failure.

  1993cites this paper
• Does Continuous Ambulatory Peritoneal Dialysis Induce Hypercholesterolemia?

  1993cites this paper
• Disturbances of lipid metabolism in children with chronic renal failure

  1993cites this paper
• Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis.

  1993cites this paper
• Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.

  1993cites this paper
• Continuos ambulatory peritonial dialysis (CAPD) 症例における高脂血症とpravastatinの効果

  1993cites this paper
• Must we Treat Uremic Dyslipidemia?

  1993cites this paper
• Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients.

  1993cites this paper
• The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis.

  1993cites this paper
• Dietary treatment of uraemia and the relation to lipoprotein metabolism.

  1992cites this paper
• Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients.

  1992cites this paper